Registration Open for Symposium on AI in Pharmaceutical Medicine.

The article discusses the impact of COVID-19 on the educational sector, specifically focusing on teaching statistics and data science during the pandemic. It highlights three papers that describe different approaches to teaching during this time. The article also includes other papers on various topics such as causal inference, qualitative methods for investigating data science skills, and personalized education. Additionally, the article announces the registration for the 2024 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine, which aims to address the challenges and opportunities of AI in pharmaceutical medicine and promote collaboration among industry, academia, regulatory agencies, and professional associations. The symposium will feature panel discussions and a keynote address by the director of the Center for Drug Evaluation and Research at the US Food and Drug Administration. [Extracted from the article]